In the fifth and final part of this video interview, Melissa Easy, VP commercial, digital products & solutions, IQVIA shares what excites her most about the future of clinical technology.
ACT: What are some potential advancements in clinical technology that you are looking forward to in the future?
Easy: I did mention before One Home for Sites, and I am personally very excited about that, because I have the chance to work across the industry. I am currently working with many other vendors that people would consider competitors, we are working with sites, we are working with many sponsors, and it is about a very positive what can we do together? We are really focused on making the sites’ lives easier. To me, I am a very collaborative person, and I love that people are bought into this, and that we are really focusing on bringing everyone together. To me, that is certainly exciting personally, but I also get very excited about how we are as an industry getting better at reducing burden on sites, so there's a lot of focus on payments and how fast you can pay a site. I think that's brilliant, because of their cash flow. I think about our patients—everything we're doing is about their safety and how we increase it. To me, that is super exciting as a person, but even how we are starting to deploy AI (artificial intelligence) and LLMs (large language models) in a way that optimizes every part of a clinical trial, because we, clearly, all in this industry, want to be able to run studies faster, but safely, so that we are getting things to patients much faster. I, even just as a human—and I think that many people would think this too—I also start to then think about how this helps us with just general diagnosis of people's health. Clearly, a lot of this starts in clinical trials, but how we can move to a more proactive and less reactive kind of way of dealing with people's health, like accurate diagnostics and risk predictions, etc. For me, that actually is one of the driving things. I got very excited there.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Managing Side Effects and Dosing in Off-Label GLP-1 Use with Help from Real-World Evidence
July 18th 2025Shipra Patel, global therapeutic area section head, endocrinology, global head, pediatrics, Parexel, explains how real-world data is helping researchers navigate gastrointestinal side effects, dose flexibility, and long-term tolerability in off-label GLP-1 use.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.